Autolus Therapeutics (AUTL) Assets Average (2017 - 2025)
Autolus Therapeutics (AUTL) has disclosed Assets Average for 8 consecutive years, with $805.1 million as the latest value for Q4 2024.
- For the quarter ending Q4 2024, Assets Average rose 106.05% year-over-year to $805.1 million, compared with a TTM value of $805.1 million through Dec 2024, up 106.05%, and an annual FY2024 reading of $579.1 million, up 33.78% over the prior year.
- Assets Average was $805.1 million for Q4 2024 at Autolus Therapeutics, down from $840.6 million in the prior quarter.
- Across five years, Assets Average topped out at $840.6 million in Q3 2024 and bottomed at $298.9 million in Q4 2020.
- Average Assets Average over 5 years is $480.6 million, with a median of $409.6 million recorded in 2023.
- The sharpest move saw Assets Average grew 3.63% in 2023, then skyrocketed 106.05% in 2024.
- Year by year, Assets Average stood at $298.9 million in 2020, then rose by 17.07% to $349.9 million in 2021, then rose by 7.76% to $377.1 million in 2022, then increased by 3.63% to $390.7 million in 2023, then soared by 106.05% to $805.1 million in 2024.
- Business Quant data shows Assets Average for AUTL at $805.1 million in Q4 2024, $840.6 million in Q3 2024, and $390.7 million in Q4 2023.